Sean Laaman
Stock Analyst at Morgan Stanley
(2.90)
# 1,594
Out of 4,876 analysts
3
Total ratings
100%
Success rate
40.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Laaman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONC BeOne Medicines | Maintains: Overweight | $313 → $330 | $243.19 | +35.70% | 1 | Jun 27, 2025 | |
| ALEC Alector | Assumes: Underweight | $3 → $1.5 | $1.47 | +2.39% | 1 | Mar 7, 2025 | |
| RMD ResMed | Upgrades: Overweight | $169 | $255.46 | -33.84% | 1 | Oct 27, 2023 |
BeOne Medicines
Jun 27, 2025
Maintains: Overweight
Price Target: $313 → $330
Current: $243.19
Upside: +35.70%
Alector
Mar 7, 2025
Assumes: Underweight
Price Target: $3 → $1.5
Current: $1.47
Upside: +2.39%
ResMed
Oct 27, 2023
Upgrades: Overweight
Price Target: $169
Current: $255.46
Upside: -33.84%